# PharmaTech is increasingly becoming a category on its own, with PitchBook's Kazi Y. Helal, PhD e...

> PharmaTech is increasingly becoming a category on its own, with PitchBook launching a dedicated research report and Q1 2024 seeing $749 million in funding across 39 deals. I think it's worth examining how they define the category, given the interesting mix of CDMO/CMO activities and AI enablement they cluster together.

URL: https://www.ch-healthtech.com/insights/pharmatech-increasingly-becoming-category-its-own-pitchbooks-kazi-y-helal-phd-e
Markdown: https://www.ch-healthtech.com/insights/pharmatech-increasingly-becoming-category-its-own-pitchbooks-kazi-y-helal-phd-e.md
Published: 2024-07-02
Updated: 2026-05-06
Author: Christian Hein
Tags: technology/artificial-intelligence, industry/tech-bio, industry/biotech, function/innovation-management, function/market-research

---


PharmaTech is increasingly becoming a category on its own, with PitchBook's Kazi Y. Helal, PhD even launching a dedicated research report. Notably, Q1 2024 saw $749 million in funding across 39 deals.

It is worth having a look at their definition of this category however, as they cluster together an interesting mix of CDMO/CMO activities, around areas like nucleic acid chemistry and Cell&Gene Therapy support, and only partially the latest evolutions in AI enablement of the pharma value chain.

https://pitchbook.com/news/reports/q1-2024-launch-report-pharmatech?utm_term=&utm_campaign=etr_market_update&utm_medium=newsletter&utm_source=weekend_pitch&utm_content=q1_2024_launch_report_pharmatech